Access to innovative therapies outside clinical trials in pediatric oncology: a national real-world analysis of off-label and compassionate use of targeted therapies and immunotherapies
Access to innovative therapies outside clinical trials in pediatric oncology: a national real-world analysis of off-label and compassionate use of targeted therapies and immunotherapies. // EJC Paediatric Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2772610X2600070X?dgcid=rss_sd_all
Access to innovative therapies outside clinical trials in pediatric oncology: a national real-world analysis of off-label and compassionate use of targeted therapies and immunotherapies. EJC Paediatric Oncology. https://www.sciencedirect.com/science/article/pii/S2772610X2600070X?dgcid=rss_sd_all
“Access to innovative therapies outside clinical trials in pediatric oncology: a national real-world analysis of off-label and compassionate use of targeted therapies and immunotherapies.” EJC Paediatric Oncology.
@article{article97845,
title = {Access to innovative therapies outside clinical trials in pediatric oncology: a national real-world analysis of off-label and compassionate use of targeted therapies and immunotherapies},
journal = {EJC Paediatric Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2772610X2600070X?dgcid=rss_sd_all}
}